Stem cell treatment, commonly referred to as regenerative medicine, uses stem cells or their byproducts to encourage the repair response of sick, malfunctioning, or wounded tissue. It is the next step in the transplantation of organs, replacing donor organs—which are scarce—with cells. In the body, stem cells have the capacity to differentiate into a wide variety of cell types. They act as the body's system for repairs. Adult stem cells and embryonic stem cells are the two primary categories of stem cells. The two main categories of stem cells are multipotent and pluripotent. Replicating cells called pluripotent stem cells are generated from foetal or embryonic tissues.
The market for Stem Cell Therapy is anticipated to reach US$ 15,075.5 million in 2022 and grow at a CAGR of 21.2% during the following five years (2022-2030).
Key Companies in the Stem Cell Therapy Industry:
1. Magellan Health Inc.
An American for-profit managed health care organisation and Centene subsidiary, Magellan Health Inc., focuses on unique populations, full pharmacy benefits, and other specialised areas of healthcare. The business was established in 1969, and Phoenix, Arizona, in the United States, serves as its corporate headquarters. By keeping an eye on the vital interpersonal connections required to achieve guiding the world towards a healthier future, Magellan promotes creative methods to reach improved health through technology. Health plans and other managed care organisations, businesses, labour unions, different military and governmental entities, and third-party administrators are just a few of Magellan's clients. The 2023 Best Workplaces USA honour was given to Magellan Federal by Energage.
2. Medipost Co., Ltd.
The development and production of stem cell biotechnology goods is what Medipost Co., Ltd. does. The following business divisions make it run: Health functional food, stem cell therapy, the import and distribution of natural cosmetics, and healthcare services are just a few examples. The division responsible for the Cord Blood Bank is engaged in the collection and storage of stem cells from newborns' umbilical cords. Allogeneic stem cell medicine products are produced by the Stem Cell Therapy division. Vitamins and nutritional supplements are available from the Health Functional Food section. Sales and marketing of natural cosmetics imported by Pevonia Inc. are handled by the Import and Distribution of Natural Cosmetics division. The Healthcare Services segment offers healthcare solutions via online, mobile, and contact centres, including bizcare, insu-care, affiliate, telehealth services, and medical equipment.Yoon-Sun Yang and Won-Il Oh formed the business on June 26, 2000, and it has its headquarters in Seongnam, South Korea.
3. Osiris Therapeutics Inc.
Osiris Therapeutics, Inc., a company established in 1992, is the pioneer in the use of universal and unique mesenchymal stem cell (MSC) and adult stem cell therapies for tissue regeneration. These "off-the-shelf" MSCs are obtained from unrelated donors' bone marrow and administered to patients without the need for immune suppression, and they constitute a workable business plan for the commercialization of stem cell treatments. The company is now concentrating on the use of universal MSCs for cardiac repair following acute myocardial infarction and congestive heart failure, bone marrow transplantation support in haematological malignancies, and regeneration of meniscus post-meniscectomy following knee injury.The business sells its goods under the GrafixPL, Bio4, Grafix, Stravix, and Cartiform names, among others. The business keeps advancing its biotechnology research and development by concentrating on regenerative medicine innovation, such as stem cell research, bioengineering, and viable tissue-based goods. Columbia, Maryland in the States serves as the headquarters of Osiris.
4. JCR Pharmaceuticals Co Ltd.
Founded on 13 September 1975, Pharmaceutical items, regenerative medicines, and drug substances are produced, sold, purchased, imported, and exported by JCR Pharmaceuticals Co Ltd (JCR). For the treatment of uncommon disorders, it offers biopharmaceuticals in the field of regenerative medicine. In addition to a regenerative medical product for acute graft-versus-host disease and other disorders, the company offers pharmaceuticals to treat growth hormone deficiency, Turner syndrome, adult growth hormone deficiency, small for gestational age, renal anaemia in dialysis patients, and anaemia of prematurity. JCR is also involved in the buying, selling, importing, and exporting of lab equipment and medical products. It has subsidiaries in the US, Switzerland, Japan, and Brazil. Ashiya, Hyogo, Japan is home to JCR's headquarters.
5. Anterogen Co.,Ltd.
The company Anterogen Co.,Ltd. produces items for cell therapy. The business provides Cupistem as an injectable for the treatment of Crohn's fistula, Queencell for the regeneration of subcutaneous adipose tissue, and Adipocell for the treatment of depressed scars. Moreover, Anterogen Co.,Ltd. provides raw materials and cosmetic goods for the beauty industry, such as SCM2, SCM2-Black, Therastem-Derma, Therastem-White Silk, and SCM2 (Human Stem cell Conditioned Media). The organisation also provides analysis and banking services for stem cells as additional services. Korea's capital city of Seoul is home to Anterogen Co.,Ltd. The business was established in 2000.
6. Pharmicell Co Ltd .
A pharmaceutical firm called Pharmicell Co Ltd (Pharmicell) finds, creates, and sells stem cell medications. Both biochemical and fine chemical goods are available from the firm. Cosmetics, robust cellgram, nucleosides, PEG derivatives, and flame retardants are just a few of the products offered by this company. Pharmicell provides services including adult stem cell and bone marrow banking. Pharmicell Co., Ltd has dedicated the last 10 years to the development of stem cell treatments for fatal illnesses. The KFDA approved Pharmicell's NDA for stem cell therapy research in 2011 as a result of their unwavering efforts and devotion. Since then, the first stem cell therapies in the world have been successfully introduced. The use of stem cell therapies to treat uncommon and incurable illnesses is well-known.
7. Stemedica Cell Technologies, Inc.
Stemedica Cell Technologies, Inc., a clinical-stage biopharmaceutical business established in 2005, focuses on the creation and marketing of progenitor cell and protein treatments for unmet medical needs. Headquarters are in San Diego, California. In a cGMP-compliant production facility, Stemedica has created a patented manufacturing technology platform that manufactures allogeneic progenitor cell products with intellectual property protection in a low-oxygen, low-tension environment. Ischemia-tolerant mesenchymal stem cells, also known as itMSCs, are an allogeneic progenitor cell therapy that is now being tested in clinical settings for the treatment of ischemic stroke and Alzheimer's disease.
*Definition: Stem cell treatment, commonly referred to as regenerative medicine, uses stem cells or their byproducts to encourage the repair response of sick, malfunctioning, or wounded tissue.
